HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) All Versions of this Article: adc.2007.120188v1 93/3/212    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in ADC Online Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Google Scholar Articles by Grote, F K Articles by van Buuren, S PubMed PubMed Citation Articles by Grote, F K Articles by van Buuren, S

Developing evidence-based guidelines for referral for short stature

¹ Department of Paediatrics, Leiden University Medical Center, Leiden, The Netherlands
² Department of Statistics, TNO Quality of life, Leiden, The Netherlands
³ Department of Paediatrics, Erasmus MC - Sophia Children’s Hospital, Rotterdam, The Netherlands
⁴ Department of Child Health, TNO Quality of life, Leiden, The Netherlands
⁵ Department of Methodology & Statistics, University of Utrecht, The Netherlands

Correspondence to:
Professor S van Buuren, Department of Statistics, TNO Quality of Life, PO Box 2215, 2301 CE Leiden, The Netherlands; Stef.vanBuuren{at}tno.nl

Objective: To establish evidence-based guidelines for growth monitoring on a population basis.

Study design: Several auxological referral criteria were formulated and applied to longitudinal growth data from four different patient groups, as well as three samples from the general population.

Results: Almost 30% of pathology can be detected by height standard deviation score (HSDS) below –3 or at least two observations of HSDS below –2.5 at a low false-positive rate (<1%) in 0–3-year-old infants. For 3–10-year olds, a rule concerning distance to target height of >2 SD in combination with HSDS <–2.0 has the best predictive value. In combination with a rule on severe short stature (<–2.5 SDS) and a minor contribution from a rule on "height deflection", 85.7% of children with Turner syndrome and 76.5% of children who are short because of various disorders are detected at a false-positive rate of 1.5–2%.

Conclusions: The proposed guidelines for growth monitoring show high sensitivity at an acceptably low false-positive rate in 3–10-year-old children. Distance to target height is the most important criterion. Below the age of 3 years, the sensitivity is considerably lower. The resulting algorithm appears to be suitable for industrialised countries, but requires further testing in other populations.

This article has been cited by other articles:

				T. Fry If it's worth doing, let's do it! Arch. Dis. Child., April 1, 2008; 93(4): 267 - 268. [Full Text] [PDF]